We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.72B
AUM Growth
+$589M
Cap. Flow
-$37.2M
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9

Top Buys

1
AMGN icon
Amgen
AMGN
+$48.3M
2
ABBV icon
AbbVie
ABBV
+$40.8M
3
SRE icon
Sempra
SRE
+$23.4M
4
CVX icon
Chevron
CVX
+$21.9M
5
HPQ icon
HP
HPQ
+$21.2M

Top Sells

1
MRK icon
Merck
MRK
+$72M
2
ENB icon
Enbridge
ENB
+$61.3M
3
MSFT icon
Microsoft
MSFT
+$45.4M
4
KMB icon
Kimberly-Clark
KMB
+$42.1M
5
VIRT icon
Virtu Financial
VIRT
+$10.4M

Sector Composition

1 Technology 17.92%
2 Healthcare 16.37%
3 Financials 13.94%
4 Industrials 11.5%
5 Consumer Staples 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.93T
$420M 4.32%
4,910,103
-553,631
-10% -$45.4M
JPM icon
2
JPMorgan Chase
JPM
$907B
$361M 3.71%
3,376,063
-52,824
-2% -$5.35M
HD icon
3
Home Depot
HD
$338B
$316M 3.25%
1,666,502
-23,331
-1% -$4.03M
PEP icon
4
PepsiCo
PEP
$187B
$300M 3.09%
2,501,071
-30,502
-1% -$3.48M
TXN icon
5
Texas Instruments
TXN
$258B
$298M 3.07%
2,857,058
+148,397
+5% +$14.4M
NEE icon
6
NextEra Energy
NEE
$185B
$286M 2.94%
7,318,484
-81,580
-1% -$3.15M
JNJ icon
7
Johnson & Johnson
JNJ
$609B
$277M 2.85%
1,980,194
-23,090
-1% -$3.22M
CSCO icon
8
Cisco
CSCO
$441B
$274M 2.81%
7,141,243
-55,755
-0.8% -$1.99M
TFC icon
9
Truist Financial
TFC
$65.4B
$273M 2.81%
5,493,352
-34,246
-0.6% -$1.65M
ABBV icon
10
AbbVie
ABBV
$450B
$247M 2.54%
2,549,457
+432,399
+20% +$40.8M
HON icon
11
Honeywell
HON
$71.3B
$241M 2.48%
1,737,155
+103,590
+6% +$13.9M
PG icon
12
Procter & Gamble
PG
$349B
$236M 2.43%
2,568,404
+30,140
+1% +$2.71M
AMGN icon
13
Amgen
AMGN
$198B
$225M 2.31%
1,292,630
+272,694
+27% +$48.3M
MMM icon
14
3M
MMM
$83.4B
$223M 2.29%
1,131,935
-30,260
-3% -$5.82M
LMT icon
15
Lockheed Martin
LMT
$117B
$208M 2.14%
646,793
+2,551
+0.4% +$804K
XOM icon
16
ExxonMobil
XOM
$611B
$198M 2.03%
2,363,196
-17,455
-0.7% -$1.44M
BLK icon
17
Blackrock
BLK
$166B
$195M 2%
378,874
-6,310
-2% -$3.07M
ABT icon
18
Abbott
ABT
$175B
$191M 1.97%
3,352,979
-65,563
-2% -$3.63M
APD icon
19
Air Products & Chemicals
APD
$65.8B
$189M 1.95%
1,154,266
+24,232
+2% +$3.86M
ITW icon
20
Illinois Tool Works
ITW
$79.4B
$174M 1.79%
1,040,631
+4,092
+0.4% +$653K
WEC icon
21
WEC Energy
WEC
$36.9B
$162M 1.67%
2,443,761
-45,289
-2% -$3.04M
PAYX icon
22
Paychex
PAYX
$40.7B
$161M 1.65%
2,359,992
-32,898
-1% -$2.16M
CCI icon
23
Crown Castle
CCI
$34.6B
$159M 1.63%
1,430,456
-7,993
-0.6% -$862K
MDT icon
24
Medtronic
MDT
$106B
$157M 1.62%
1,946,030
+154,380
+9% +$12.4M
MO icon
25
Altria Group
MO
$124B
$155M 1.59%
2,164,616
-34,501
-2% -$2.31M
1
2 3 4 5

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Bahl & Gaynor's Q4 2017 Portfolio in Review

As of Q4 2017, Bahl & Gaynor held 419 positions worth $9.72B, up 6.4% from $9.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2017 filing shows 23 new, 181 increased, 152 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 534,010 shares worth $9.63M. The largest sale was Merck, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2017 buy was iShares Core High Dividend ETF: 534,010 shares worth $9.63M.
  • Bahl & Gaynor added most to Amgen in Q4 2017, an estimated $48.3M increase.
  • Bahl & Gaynor's biggest Q4 2017 reduction was Merck, cutting an estimated $72M.
  • Bahl & Gaynor fully exited Virtu Financial in Q4 2017, selling an estimated $10.4M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $9.72B portfolio in Q4 2017.
  • Bahl & Gaynor opened 23 new positions and closed 9 in Q4 2017.
  • Bahl & Gaynor's portfolio value rose 6.4% quarter-over-quarter to $9.72B.

Based on Bahl & Gaynor's 13F filing for Q4 2017, filed 13 Feb 2018.